See today's BioWorld MedTech
To read the full story, subscribe or sign in.

Edwards' Konect Resilia gets thumbs up from the FDA

July 16, 2020
By Liz Hollis
Edwards Lifesciences Corp. has scored an approval from the U.S. FDA for the Konect Resilia aortic valved conduit, a ready-to-implant solution for bio-Bentall procedures.
BioWorld MedTech Regulatory Cardiovascular FDA